Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
22 June, 2017 21:58 IST
Lupin receives USFDA nod for generic Seroquel XR tablets
Source: IRIS | 19 May, 2017, 08.20AM
Comments  |  Post Comment

Pharma Major Lupin announced today that it has received final approval for its Quetiapine Fumarate Extended-Release Tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg from the United States Food and Drug Administration (FDA) to market a generic version of AstraZeneca Pharmaceuticals LP's Seroquel XR Tablets 50 mg, 150 mg, 200 mg, 300 mg and 400 mg.

Lupin's Quetiapine Fumarate Extended-Release Tablets, 50 mg, 150 mg, 200 mg, 300 mg and 400 mg are the AB rated generic equivalent of AstraZeneca Pharmaceuticals LP's Seroquel XR Tablets 50 mg, 150 mg, 200 mg, 300 mg and 400 mg.

It is indicated for the treatment of schizophrenia; acute manic or mixed episodes in bipolar I disorder alone or as an adjunct to lithium or divalproex; acute depressive episodes in bipolar disorder; maintenance treatment of bipolar I disorder, as an adjunct to lithium or divalproex and as an adjunctive therapy to antidepressants for the treatment of major depressive disorder.

Seroquel XR Extended-Release Tablets had US sales of USD 1.27 billion (IMS MAT March 2017).

Shares of the company gained Rs 7.85, or 0.61%, to trade at  Rs 1,304.90.  The total volume of shares traded  was  67,273 at the BSE (4.01 p.m., Thursday).



Lupin Limited   (Q,N,C,F)*

Comments Post comment 
 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
Strides Shasun, Vivimed Labs achieve closure to set up JV in India, Singapore - 22-Jun-2017 14:26
PI Industries enters into JV agreement with Kumiai Chemical - 22-Jun-2017 14:22
Lupin launches generic Topicort LP Emollient Cream, Topicort cream in US - 22-Jun-2017 14:17
Prism Cement's arm completes expansion of vitrified tiles capacity at Morbi - 22-Jun-2017 10:27
Nila Infra bags work order worth Rs 251.6 mn from AMC - 22-Jun-2017 10:25
NHPC inks MoU with Ministry of Power for 2017-18 - 22-Jun-2017 10:21
Glenmark Pharma gets tentative approval for generic Vesicare tablets - 22-Jun-2017 10:11
Alembic Pharma receives USFDA nod for Amantadine HCl capsules - 22-Jun-2017 10:04
HDFC Bank partners with ZineOne for rich digital banking experience - 21-Jun-2017 16:04
Reliance Defence to form JV with French Co Thales - 21-Jun-2017 14:04
Reliance Defence to form JV with French Co Thales - 21-Jun-2017 14:04
more...
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer